BioNTech, Pfizer Covid-19 Vaccine Safe, Well-Tolerated & Robust in Children 5-11 Years

Montag, 20.09.2021 12:55 von PLX

• (PLX AI) – Pfizer and BioNTech Announce Positive Topline Results from Pivotal Trial of COVID-19 Vaccine in Children 5 to 11 Years.
• • Companies say in participants 5 to 11 years of age, the vaccine was safe, well tolerated and showed robust neutralizing antibody responses
• • BioNTech and Pfizer to submit these data to the FDA, EMA and other regulatory agencies around the world as soon as possible